Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT02500251
Brief Title:
Belimumab Impacting Transplant Eligibility
Official Title:
Belimumab-Based Plasma Cell Targeted Therapy to Impact Transplant Eligibility
Study:
NCT02500251
Protocol Section:
NCT02500251